Announcements Trials

Browse Landscape

Phase

Status

Completed 2 Terminated 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 7 Hodgkin Disease 7 Multiple Myeloma 6 Leukemia 6 Neoplasm Metastasis 5 Myelodysplastic Syndromes 5 Lymphoma, Non-Hodgkin 5 Lymphoma 5 Leukemia, Myeloid, Chronic-Phase 5 Leukemia, Lymphocytic, Chronic, B-Cell 5 Prostatic Neoplasms 4 Neoplasms 4 Leukemia, Myeloid, Acute 4 Leukemia, Myeloid, Accelerated Phase 4 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 4 Graft vs Host Disease 4 Blast Crisis 4 Sarcoma 3 Primary Myelofibrosis 3 Pancreatic Neoplasms 3 Myelodysplastic-Myeloproliferative Diseases 3 Lymphoma, Large B-Cell, Diffuse 3 Burkitt Lymphoma 3 Breast Neoplasms 3 Waldenstrom Macroglobulinemia 2 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 2 Neoplasms, Plasma Cell 2 Myeloproliferative Disorders 2 Lymphoma, Mantle-Cell 2 Lung Neoplasms 2

Interventions

pazopanib 2 thymoglobulin 1 sapanisertib 1 pexidartinib 1 pembrolizumab 1 fludarabine phosphate 1 Trabectedin 1 Thiotepa 1 Tacrolimus 1 Stem Cell Transplantation 1 Sirolimus 1 Radiotherapy, Intensity-Modulated 1 Polymerase Chain Reaction 1 Neoadjuvant Therapy 1 Mycophenolic Acid 1 Melphalan 1 Imatinib Mesylate 1 Gene Expression Profiling 1 Etoposide 1 Doxorubicin 1 Docetaxel 1 Cyclosporins 1 Cyclosporine 1 Blotting, Western 1 Antilymphocyte Serum 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Terminated × Neurofibrosarcoma × Sirolimus × Clear all

NCT02584647 2025-03-21

PLX3397

Columbia University

Phase 1/2 Terminated

39 enrolled 13 charts

Sarcoma, Neurofibrosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡